Hedrich Olaf, Estes N A Mark, Link Mark S
Tufts-New England Medical Center, Cardiac Arrhythmia Service, Division of Cardiology, 750 Washington Street, Box #197,Boston, MA 02111, USA.
Curr Cardiol Rep. 2006 Sep;8(5):316-22. doi: 10.1007/s11886-006-0069-z.
The impact of sudden cardiac death (SCD) in athletes has been highlighted by increasing media coverage, as well as medical and lay awareness of the entities associated with SCD. Common etiologies include cardiac abnormalities such as hypertrophic cardiomyopathy (HCM), arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD), and coronary artery anomalies, each with varying geographic incidence. New recommendations regarding noninvasive preparticipation screening have emerged in Europe, where the Italian experience of mandatory annual screening of athletes has been the forerunner in efforts to identify individuals at risk. Ongoing clinical efforts are underway to help define the role of implantable cardioverter defibrillators as a preventive measure in appropriate candidates with HCM or ARVD, as well as methods to limit the potential for SCD as a result of chest blows sustained in sports and other recreational activities by means of chest protectors and special sporting equipment for young athletes.
运动员心源性猝死（SCD）的影响因媒体报道增多以及医学和公众对与SCD相关实体的认识提高而受到关注。常见病因包括心脏异常，如肥厚型心肌病（HCM）、致心律失常性右室发育不良/心肌病（ARVD）和冠状动脉异常，每种病因的地理发病率各不相同。欧洲出现了关于非侵入性赛前筛查的新建议，意大利对运动员进行年度强制筛查的经验一直是识别高危个体努力的先驱。目前正在进行临床研究，以帮助确定植入式心脏复律除颤器在HCM或ARVD合适候选者中作为预防措施的作用，以及通过胸部保护器和针对年轻运动员的特殊运动装备来限制因运动和其他娱乐活动中胸部受到撞击而导致SCD的可能性的方法。
